Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Frank Vanpachtenbeke

Ghent University Hospital

Work address: Radiotherapie C. Heymanslaan 10
9000 Gent
Email: FRANK.VANPACHTENBEKE@UGent.be

Show Sort by

Mark
4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie Fonteyne (UGent) , Camille Sarrazyn, Martijn Swimberghe (UGent) , Gert De Meerleer (UGent) , Elke Rammant (UGent) , Barbara Vanderstraeten (UGent) , Frank Vanpachtenbeke (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Roos Colman (UGent) , et al.

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.866-870
Mark
Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer : a 10-years single centre experience

VALERIE FONTEYNE, SIMIN SADEGHI, Piet Ost (UGent) , Frank Vanpachtenbeke (UGent) , Philippe Vuye (UGent) , Nicolaas Lumen (UGent) and Gert De Meerleer (UGent)

(2015) ACTA ONCOLOGICA. 54(6). p.854-861
Mark
Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?

VALERIE FONTEYNE, Piet Ost (UGent) , Frank Vanpachtenbeke (UGent) , Roos Colman (UGent) , SIMIN SADEGHI, Geert Villeirs (UGent) , Karel Decaestecker (UGent) and Gert De Meerleer (UGent)

(2014) RADIOTHERAPY AND ONCOLOGY. 113(3). p.398-403
Mark
Reliability and accuracy assessment of radiation therapy oncology group-endorsed guidelines for brachial plexus contouring

Joris Van de Velde (UGent) , Tom Vercauteren (UGent) , Werner De Gersem (UGent) , Johan Wouters (UGent) , Katrien Vandecasteele (UGent) , Philippe Vuye (UGent) , Frank Vanpachtenbeke (UGent) , Katharina D'Herde (UGent) , Ingrid Kerckaert (UGent) , Wilfried De Neve (UGent) , et al.

(2014) STRAHLENTHERAPIE UND ONKOLOGIE. 190(7). p.628-635